Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Odense – page 15

483 clinical trials in Odense, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Odense at a glance
483
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

483 trials in Odense

Open in trial search

Study on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil
  • Sponsor:United Therapeutics Corp.

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Princess Maxima Center For Pediatric Oncology

Glioblastoma

Recruiting

Study on Glioblastoma Recurrence: Comparing SonoCloud-9 with Carboplatin to Standard Treatments Lomustine or Temozolomide for Patients Undergoing Tumor Removal Surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Carthera

Study on the Effects of Amiloride in Patients with Chronic Kidney Disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Odense University Hospital

Osteomyelitis

Recruiting

Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Hovedstaden

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Study on Triamcinolone Acetonide Injections to Prevent Esophageal Strictures in Children with Esophageal Atresia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Triamcinolone Acetonide
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study on Venetoclax and Epcoritamab for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Region Oerebro Laen

Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Odense

What the registry says about research in the country

01 Respiratory and Pulmonary Research

Clinical investigations focusing on Idiopathic Pulmonary Fibrosis and chronic respiratory conditions. Studies evaluating new therapeutic approaches for managing nasal polyps and chronic rhinosinusitis.

  • Pulmonary Fibrosis Treatment
  • Nasal Polyps Management
  • Chronic Rhinosinusitis

Trials aim to assess innovative treatments and monitor long-term disease control.

02 Oncology Studies

Comprehensive research into various cancer types, including bladder cancer, metastatic breast cancer, and prostate cancer. Focus on innovative therapies and treatment combinations.

  • Cancer-Related Fatigue
  • Advanced Breast Cancer
  • Prostate Cancer Therapy

Studies evaluate novel treatment approaches and drug combinations for better patient outcomes.

03 Autoimmune and Inflammatory Conditions

Research focusing on Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis. Studies of treatments for Sjögren's Syndrome and immune thrombocytopenia.

  • Gastrointestinal Disorders
  • Immune System Disorders
  • Chronic Inflammatory Conditions

Trials assess both established and experimental therapies for inflammatory conditions.

04 Cardiovascular and Renal Studies

Investigations into chronic kidney disease, heart conditions, and transplant outcomes. Research includes studies on aortic stenosis and myocardial infarction treatments.

  • Kidney Transplantation
  • Cardiac Conditions
  • Renal Disorders

Focus on improving treatment outcomes and patient care in cardiovascular and renal conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.